Pathfinders in Biopharma

Perspectives from the cutting edge of biotech and pharma, with industry experts turning change into a competitive advantage.

Listen and subscribe on:

Apple PodcastsSpotifyGoogle Podcasts

Explore the latest episodes

Search podcast

JUN 17, 2026

Why the MFN price battle is heading for court, not legislature

Where does U.S. healthcare policy and regulation stand – and what will be the impact of any political shake-up in November?

 14 min 3 min

JUN 17, 2026

4DMT targets global retina market with long-lasting genetic treatment

4D Molecular Therapeutics' Chris Simms on next-gen AAV genetic medicines for retinal diseases and driving innovation for global growth.

 17 min 4 min

JAN 27, 2026

No biotech bubble – but can the sector’s rally persist through 2026?

Can biotech sustain its renewed momentum in 2026, or have the biggest near-term opportunities already been captured? Listen now.

 13 min 3 min

OCT 6, 2025

Conversations in the U.S.

Frustrated describes the tone we heard in some of last week’s conversations, especially with Small Cap core and growth-focused investors.

 7 min 2 min

SEP 18, 2025

MindMed: Rethinking brain health with psychedelic therapy

CEO Rob Barrow discusses MindMed’s ambitious goals and how the company is helping to forge a new era of psychiatry by applying scientific...

 11 min 3 min

Load more episodes

Stay ahead of the curve

Explore the fast-moving world of biopharma and what's next for companies and investors.

Subscribe now

Explore more RBC Capital Markets podcasts

Stay informed

Get the latest insights from RBC Capital Markets delivered to your inbox.